A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO), ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...

Each week Tash Coetzer injects herself with a drug, which arrives by courier, designed to suppress her appetite.

14%). The company has faced failure to meet the weight-loss target with its CagriSema injection treatment twice, which caused Novo Nordisk a huge setback. Intense rivalry in the obesity sector ...

over 10 years Gregory Bojorquez/Getty; Prince Williams/FilmMagic Fat Joe is opening up about his transformative weight loss journey. The "Lean Back" rapper appeared on the April 9 episode of 3rd ...

Ireland, with its low corporate tax rate, is a hub for production of the active ingredients in blockbuster medicines, including Lilly's weight-loss injection ... office. Novo Nordisk and others ...

Chris Wilder’s Sheffield United suffered a disappointing loss at home to Millwall (Picture: Getty) Chris Wilder took aim at referee Sam Allison following Sheffield United’s 1-0 defeat to ...